Not long ago considered incurable — today, targeted therapy and immunotherapy offer real, lasting hope to lung cancer patients.
Dr. Anil Singhvi, MD · 35+ years · Founded Madhya Pradesh's first hematology centreConsult in person in Indore, or by video call.
Lung cancer starts in the airways or lung tissue, and smoking is its biggest risk factor — though non-smokers, particularly women, develop it too. Because early lung cancer often causes no symptoms, many patients are diagnosed at a later stage.
The treatment revolution of the last decade has changed what a lung cancer diagnosis means. Testing the tumour for specific gene changes lets us match many patients to targeted tablets or immunotherapy, with far better results and fewer side effects than older chemotherapy alone.
Evaluation includes a chest CT scan and a biopsy — by bronchoscopy or a CT-guided needle — to confirm the type of lung cancer. Molecular testing of the biopsy (for mutations such as EGFR and ALK) and PD-L1 testing guide the choice between targeted therapy, immunotherapy, and chemotherapy. Staging scans complete the picture.
Early-stage disease may be cured with surgery or radiation. For advanced disease, treatment is matched to the tumour's biology: oral targeted drugs for mutation-positive cancers, immunotherapy to help the body's own defences fight the tumour, and modern chemotherapy — often in combination. Many of these treatments are given on a day-care basis.
This information is for general education and is not a substitute for a consultation. Every patient is unique — the right treatment can only be decided after proper evaluation.
Dr. Anil explains how modern treatment has made cancer curable.
Get an expert opinion from a specialist with over three decades of experience treating cancers and blood disorders. Second opinions and online consultations welcome.
Book on WhatsApp